INTEGRA LIFESCIENCES HOLDINGS CORP (IART) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.
Key numbers for INTEGRA LIFESCIENCES HOLDINGS CORP (IART): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.
AllSight quality score: 41/100 — a percentile rank of INTEGRA LIFESCIENCES HOLDINGS CORP’s fundamentals against Manufacturing peers, weakest on growth. A quality ranking, not a price prediction.
| Market cap | $1.3B |
| P / S | 0.8× |
| EV / EBITDA | 13.3× |
| Gross margin | 52.5% |
| Operating margin | 4.0% |
| Net margin | -0.4% |
| Return on equity | -0.7% |
| ROIC | 98.2% |
| Revenue growth | 1.6% |
| Debt / equity | 1.8× |
| Dividend yield | 0.0% |
Is INTEGRA LIFESCIENCES HOLDINGS CORP overvalued? P/S looks undervalued vs its 5-year range; EV/EBITDA looks undervalued vs its 5-year range; P/B looks fair vs its 5-year range.
Independent of the events above — derived from INTEGRA LIFESCIENCES HOLDINGS CORP’s own financial statements and shown as context, never as advice.
About AllSight · Editorial standards & method · Contact